Hypothesis

Intermittent, not continuous, reduction of METTL3/14‑mediated m6A methylation creates a hormetic oscillation that alternately suppresses translation of autophagy inhibitors and boosts synthesis of synaptic proteins, thereby preserving proteostasis in aging neurons. Chronic METTL3/14 loss, as seen in pathological aging, locks the system in a low‑m6A state that stalls ribosomes, promotes persistent stress granules, and drives irreversible synaptic decline.

Mechanistic Rationale

• mTORC1 → METTL3/14 axis: mTORC1 stabilizes METTL3/14 via the CCT chaperonin complex, increasing m6A on ATG transcripts and targeting them for decay [https://www.pnas.org/doi/10.1073/pnas.2021945118]. Inhibition of mTORC1 (by rapamycin or fasting) destabilizes METTL3/14, lowering m6A on ATG mRNAs and derepressing autophagy.
• Opposing transcript classes: In neurons, a subset of synaptic‑plasticity mRNAs (e.g., Bdnf, Arc, Camk2a) are enhanced by low m6A because their 5′‑UTR structures favor cap‑independent initiation when m6A‑dependent repression is relieved. Conversely, many autophagy‑regulators are repressed by m6A loss due to increased RNA decay via YTHDF2.
• Pulsatile dynamics: Short bursts of mTOR inhibition produce a transient dip in METTL3/14, causing a wave of autophagy (clearing damaged organelles) followed by a rebound in METTL3/14 as nutrients return. The rebound restores m6A on synaptic transcripts, allowing a synchronized surge in translation that replenishes synaptic proteins degraded during the autophagic phase.
• Chronic loss: Persistent METTL3/14 depletion prevents the rebound phase. Ribosomes initiate on hypomethylated synaptic mRNAs but stall because m6A also promotes efficient elongation and ribosome recycling. Stalled ribonucleoprotein complexes seed stress granules that fail to disassemble, sequestering translation factors and exacerbating proteostatic stress.
• Net effect: Oscillatory m6A yields a net gain in functional protein turnover (autophagy + synthesis), whereas static low m6A yields a net loss (translation inhibition + granule persistence).

Testable Predictions

1. Inducible METTL3/14 knockdown in aged mouse neurons
   • Pulsatile (e.g., 2‑hr doxycycline off/on cycles) will increase LC3‑II flux and synaptic protein levels (PSD‑95, Synapsin‑1) relative to continuous knockdown.
   • Measure via Western blot, immunofluorescence, and ribopuromycylation assay (SUnSET) to capture translation bursts.
2. Stress‑granule dynamics
   • Live‑cell imaging of G3BP1‑GFP will show rapid granule assembly during mTOR inhibition bursts and complete disassembly during recovery only in the pulsatile condition; continuous knockdown will produce persistent granules.
3. Behavioral and lifespan readouts
   • Mice receiving intermittent rapamycin (e.g., 5‑day on/2‑day off) will exhibit improved spatial memory (Morris water maze) and extended median lifespan compared to those receiving constant low‑dose rapamycin, correlating with neuronal METTL3/14 oscillation amplitude measured by immunoblot of microdissected hippocampus.
4. Rescue experiment
   • Overexpressing a methylation‑resistant Bdnf 5′‑UTR mutant in continuously METTL3/14‑deficient neurons should restore synaptic protein levels without affecting autophagy, confirming that translational dysregulation, not autophagy failure, drives the deleterious phenotype.

Potential Pitfalls & Alternative Explanations

• Compensatory upregulation of other m6A writers (METTL16, ZC3H13) could mask METTL3/14 loss; we will quantify total m6A levels via MeRIP‑seq to ensure observed changes are specific.
• Rapamycin has mTORC2‑independent effects; using ATP‑competitive mTOR kinase inhibitors (e.g., AZD8055) will help isolate mTORC1‑specific contributions.
• If pulsatile METTL3/14 reduction fails to improve outcomes, the hypothesis would be falsified, suggesting that longevity benefits arise from non‑transcriptional mechanisms (e.g., direct mTORC1 inhibition of SASP).

By linking the temporal pattern of m6A modulation to opposing translational programs, this hypothesis transforms the "impersonating a harder life" metaphor into a testable rhythm of molecular stress and recovery, distinguishing adaptive hormesis from pathological decline.